Monopolar Radiofrequency with Vibration and Cryogen Cooling
NEW $60,000-$110,000USED $25,000-$50,000FDA Cleared 2017
Last updated: 2026-04-09
Overview
Thermage FLX is Solta Medical's entry in the skin tightening category, built on Monopolar Radiofrequency with Vibration and Cryogen Cooling. The platform treats face, eyelids, neck, abdomen, thighs, arms, with 30-90 minutes and a recommended course of 1 session, maintenance every 12-18 months. FDA cleared in 2017, it lists in the $60,000-$110,000 range for new units and $25,000-$50,000 on the secondary market.
The only FDA-cleared single-session non-invasive skin tightening device with a heart symbol tip that maps treatment pulses in real-time. Vibration reduces patient discomfort versus earlier Thermage generations. The mechanism is what separates Thermage FLX from competitors in the same category. Where it fits in your practice depends on patient demographics, treatment volume, and whether you need a flagship platform or a value-tier alternative.
Thermage FLX is manufactured by Solta Medical (Bothell, WA, founded 1996). The device benefits from Solta Medical's public market visibility and presence across 75+ countries. Service support, training availability, and parts access vary by region. Practices considering this device should validate dealer presence and technical support coverage in their area before signing a contract.
TREATMENT AREAS
Face, Eyelids, Neck, Abdomen, Thighs, Arms
TREATMENT TIME
30-90 minutes
SESSIONS
1 session, maintenance every 12-18 months
PER SESSION
$1,800-$5,000
CONSUMABLES/YR
$15,000-$40,000 (treatment tips)
MAINTENANCE/YR
$4,000-$8,000
Pros & Cons
Pros
Single-session treatment has the highest per-visit revenue in the category
Strong brand recognition drives patient demand
AccuREP technology adjusts energy per pulse for more consistent results
FDA-cleared for eyelids (few competitors hold this indication)
Vibration and cooling make treatment more comfortable than older Thermage units
Cons
Treatment tip consumable costs are the highest in the category (up to $1,800 per tip)
Solta parent Bausch Health has carried heavy debt for years
Results take 2-6 months to develop fully
Operator experience matters a lot to final outcome
Patient comfort still requires topical or oral pain control
Clinical Evidence
75+ published studies across the Thermage platform. Strong outcome data for face, eyes, and body skin laxity. The published evidence base for Thermage FLX reflects how long the platform has been in market and how much the manufacturer has invested in clinical research. Devices with FDA clearance dates before 2018 typically have stronger peer-reviewed datasets than newer entrants. For physicians evaluating this device, the questions worth asking are whether the studies used blinded evaluators, what the sample sizes were, and whether the research was independent or manufacturer-funded.
Compare Thermage FLX's evidence base against the category benchmark. In Thermage FLX's category, the strongest evidence typically comes from devices that have been on the market for at least five years and have multiple randomized controlled trials with independent funding. Marketing claims from any manufacturer should be cross-checked against PubMed-indexed publications rather than conference posters or white papers. Conference presentations are not equivalent to peer review.
For practices that require strong clinical evidence (academic dermatology, plastic surgery groups with research interests, multi-physician practices that need to defend purchase decisions internally), the evidence profile should be a top-three decision factor. For high-volume cash-pay practices where patient demand drives device selection, brand recognition often matters more than the underlying evidence base. Both approaches are defensible, but they lead to different device selections.
ROI Analysis
Practice ROI for Thermage FLX depends on three variables: capital cost, per-session revenue, and treatment volume. At a new unit price of $60,000-$110,000, financed over five years at typical equipment rates, the monthly payment runs roughly 2-2.5% of total cost. Per-session revenue at $1,800-$5,000 means the device needs to fill enough treatment slots monthly to cover the payment, consumables ($15,000-$40,000 (treatment tips)), maintenance ($4,000-$8,000), and operator labor.
For a practice doing 2-3 treatments per day at the midpoint of the per-session range, Thermage FLX typically reaches break-even at 12-18 months for the lower end of the new pricing range, or 18-30 months at the high end. Used and refurbished units in the $25,000-$50,000 range can cut payback periods in half. The biggest practice mistake is over-projecting treatment volume. Physicians who run their numbers on 4-6 daily treatments rarely hit those targets in year one.
The realistic question is not whether Thermage FLX can pay back. Most devices in this price range do, eventually. The question is whether your practice can fill the schedule. Practices with existing patient flow in Dermatology, Plastic Surgery have the easiest path. Practices building demand from scratch should plan for 6-12 months of marketing investment before the device pays for itself.
Best For
High-end dermatology, plastic surgery, and luxury med spas that serve patients who want a single-session option. Practices with established skin tightening patient demand. The fit is strongest for practices that match the device's positioning on price, clinical evidence requirements, and patient throughput expectations. Practices with mismatched economics often regret these purchases within 18 months.
Beyond practice type, Thermage FLX fits best when the patient base aligns with the device's strengths. For skin tightening platforms, this usually means matching device capability to patient demographics, skin type range, and willingness to pay per-session pricing. Practices in markets where patients price-shop heavily need to factor that into device selection. Practices in concierge or luxury markets can charge premium pricing that justifies premium platforms.
Buying Guide
New Thermage FLX units sell for $60,000-$110,000 from Solta Medical or authorized dealers. Refurbished and used units sell for $25,000-$50,000 on the secondary market. The decision between new and used comes down to warranty coverage, software version, included applicators, and consumable allowances. New units typically include a 12-24 month warranty, current software, all applicators, and a starter consumable package. Used units usually carry no warranty, may have outdated software, and require separate consumable purchases.
What to negotiate: applicator quantity (always ask for additional applicators thrown in), consumable starter packs, training and certification fees, extended warranty coverage, marketing materials, and clinical training for additional providers. Solta Medical sales reps typically have 10-15% list price flexibility and far more on bundled deals. End-of-quarter and end-of-year are the strongest negotiation windows. Trade-in programs for older devices can reduce net cost by another 10-20%.
What to watch for: software lock-out fees on used units (some manufacturers disable software on resold devices), per-pulse or per-treatment licensing fees that show up after purchase, consumable price increases over the device life, and service contract terms. Always require a written quote that breaks out hardware, applicators, training, first-year service, and consumables separately. Bundled quotes hide the line items where margins live.
Alternatives and Comparisons
The main alternatives to Thermage FLX in this category are listed below. Click into any comparison for a full side-by-side breakdown.
Ultherapy: Dermatology and plastic surgery practices that serve patients declining surgery but wanting measurable lift. Premium med spas with established demand for single
TempSure Firm: Med spas that want a lower-cost RF body tightening platform than Thermage and are comfortable with the Cynosure situation. Practices serving patients who want m
Exilis Ultra 360: Med spas wanting a multi-area tightening platform at a lower capital cost than Thermage or Ultherapy. BTL ecosystem practices building out a full treatment menu
Morpheus8: Practices wanting the most recognized RF microneedling brand with body treatment capability. High-volume aesthetic practices where patient demand drives device
New Thermage FLX units sell for $60,000-$110,000 from Solta Medical and authorized dealers. Used and refurbished units typically run $25,000-$50,000 on the secondary market depending on age, software version, and included applicators. Per-session pricing for treatments is $1,800-$5,000. Annual consumables run $15,000-$40,000 (treatment tips) and annual maintenance averages $4,000-$8,000. Practices financing the device should expect monthly payments around 2-2.5% of the total purchase price over a five-year term.
Is Thermage FLX FDA cleared?
Yes. Thermage FLX received FDA 510(k) clearance in 2017. The clearance covers the indications listed in the device labeling. Off-label uses are common in clinical practice but should be discussed with patients explicitly. Physicians should verify current clearance status and any updates directly with Solta Medical or via the FDA 510(k) database before making a purchase decision.
What is the clinical evidence behind Thermage FLX?
75+ published studies across the Thermage platform. Strong outcome data for face, eyes, and body skin laxity. When evaluating clinical evidence, look for blinded evaluator studies, independent funding sources, and peer-reviewed publications rather than manufacturer-funded white papers or conference posters. Evidence quality varies widely between devices in the same category, even when the marketing materials look similar.
Which specialties use Thermage FLX?
Thermage FLX is primarily used by Dermatology, Plastic Surgery, Med Spa. Best fit varies by patient mix and practice economics. High-end dermatology, plastic surgery, and luxury med spas that serve patients who want a single-session option. Practices with established skin tightening patient demand.
How long does a Thermage FLX treatment session take?
Each Thermage FLX treatment session runs 30-90 minutes. The recommended protocol is 1 session, maintenance every 12-18 months. Total chair time including consultation, setup, treatment, and post-treatment care is typically 1.5-2x the listed treatment time. Practices planning daily treatment volume should use the realistic chair-time number, not just the active treatment minutes.
What are the main pros and cons of Thermage FLX?
Strengths: Single-session treatment has the highest per-visit revenue in the category; Strong brand recognition drives patient demand; AccuREP technology adjusts energy per pulse for more consistent results. Weaknesses: Treatment tip consumable costs are the highest in the category (up to $1,800 per tip); Solta parent Bausch Health has carried heavy debt for years; Results take 2-6 months to develop fully. Every device in this category has tradeoffs. The right choice depends on which strengths matter most to your practice and which weaknesses you can tolerate.
What does Thermage FLX cost to operate annually?
Annual operating costs for Thermage FLX include consumables ($15,000-$40,000 (treatment tips)), maintenance and service ($4,000-$8,000), and operator labor. Practices doing high treatment volumes should also budget for additional applicator wear and replacement. Total annual operating cost typically runs 5-15% of the original purchase price, with consumables driving most of the variability between low and high estimates.
Who manufactures Thermage FLX and how stable is the company?
Thermage FLX is manufactured by Solta Medical, headquartered in Bothell, WA and founded in 1996. The company is publicly traded under ticker BHC and operates in 75+ countries. Annual revenue is approximately Part of Bausch Health ($4.5B+). Manufacturer financial stability matters because it affects warranty support, parts availability, and long-term software updates. Physicians making capital purchases should always check the manufacturer's recent financial trajectory before committing.
Get Device Pulse every Tuesday
Weekly price tracker, FDA clearances, safety signals, and clinical evidence summaries. The only newsletter built for physicians who buy equipment.